Chris Markoch

Chris Markoch

Chris Markoch is a freelance financial writer who brings over 25 years in sales and marketing to help find the story behind the stock. Chris starts by asking the question, “So what?” and then uses fundamental and (some) technical analysis to add depth to that insight.

Stepping back from the “what” allows Chris to bring perspective that helps investors make wise decisions based on their risk tolerance and investing timeline.

Markoch would describe his writing as being for investors more than traders. He looks at equities through a long-term lens and that is reflected in his writing.

In addition to his articles on InvestorPlace, you can also find Chris’ writing on MarketBeat.com where he has collaborated on the e-book “5 Investing Trends That Will Define the Market in 2022.” You can find Chris on LinkedIn and on Twitter.

Recent Articles

The Naked Brands Merger Is Either a Brilliant Move or a Cautionary Tale

Retail speculation helped Naked Brands pay off debt and pivot to the EV space. NAKD stock will either be a great story or cautionary tale.

Treat Virgin Galactic as a Lottery Ticket and You May Avoid Being Disappointed

SPCE stock could turn out to be a moonshot. Its fate depends on how well Virgin Galactic executes its plans.

Shiba Inu May Go Mainstream in a Way That Takes Some of the Shine Off

If the recent price action in Shiba Inu shows investors are taking a more practical approach to the altcoin, it may cause the SHIB army to look for a new battle

The Bullish Case for Novavax Stock Is Based on Opinion Not Fact

Conventional wisdom suggests that if Novavax gets an EUA for its Covid-19 vaccine, it will be bullish for NVAX stock. That fact may not hold up to public opinion.

Lucid Motors Stock Has Opportunities for Bulls and Bears Alike

The sharp selloff in LCID stock tied to the announcement of an SEC investigation creates a scenario that is likely to cause bulls and bears to dig in their heels